介入放射学杂志2023年2月第32卷第2期JInterventRadiol2023,Vol.32,No.2·血管介入Vascularintervention·3%聚多卡醇联合无水乙醇硬化治疗肢体静脉畸形的效果王世知，赵文鹏，周为民【摘要】目的探讨DSA导引下经皮注射3%聚多卡醇联合无水乙醇治疗肢体静脉畸形的临床效果。方法收集2019年7月至2020年7月南昌大学第二附属医院收治的32例肢体静脉畸形患者临床资料。其中男12例，女20例，年龄10～52岁。根据术前MRI检查和术中血管造影，Puig分型Ⅰ型6例，Ⅱ型20例，Ⅲ型3例，Ⅳ型3例。所有患者均在局部麻醉下接受3%聚多卡醇联合无水乙醇硬化治疗。术后4周复查MRI，记录病灶大小并计算病灶缩小率。随访6～12个月。结果32例中26例为低回流型静脉畸形，6例为高回流型静脉畸形。术后6例PuigⅠ型患者治愈，20例Ⅱ型患者基本治愈，6例Ⅲ、Ⅳ型患者均有效，治疗有效率为100%。出现局部张力性水泡2例，局部色素沉着3例，未出现皮肤坏死表现。结论3%聚多卡醇联合无水乙醇硬化治疗肢体静脉畸形安全有效，并发症较少。【关键词】静脉畸形；硬化疗法；聚多卡醇；无水乙醇中图分类号：R543文献标志码：A文章编号:1008-794X（2023）-02-0123-04TheclinicaleffectofDSA-guidedpercutaneoussclerotherapyusing3%polidocanolcombinedwithabsoluteethanolinthetreatmentofvenousmalformationoflimbsWANGShizhi,ZHAOWenpeng,ZHOUWeimin.DepartmentofVascularSurgery,SecondAffiliatedHospitalofNanchangUniversity,Nanchang,JiangxiProvince330006,ChinaCorrespondingauthor:WANGShizhi,E-mail:119456283@qq.com【Abstract】ObjectiveToinvestigatetheclinicaleffectofDSA-guidedpercutaneousinjectionof3%polidocanolandabsoluteethanolinthetreatmentofvenousmalformationoflimbs.MethodsTheclinicaldataof32patientswithvenousmalformationoflimbs,whoweretreatedintheSecondAffiliatedHospitalofNanchangUniversityofChinabetweenJuly2019andJuly2020,werecollected.The32patientsincluded12malesand20females,aged10-52years.AccordingtopreoperativeMRIandintraoperativeangiographyfindings,6patientswereofPuigtypeⅠ,20patientswereofPuigtypeⅡ,3patientswereofPuigtypeⅢand3patientswereofPuigtypeⅣ.Underlocalanesthesia,percutaneoussclerotherapyusing3%polidocanolcombinedwithabsoluteethanolwascarriedoutinallpatients.MRIreexaminationwasperformed4we...
